JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB31392

Anti-PTEN antibody

4

(5 Reviews)

|

(102 Publications)

Rabbit Polyclonal PTEN antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 102 publications. Immunogen corresponding to Synthetic Peptide within Human PTEN aa 350-400.

View Alternative Names

MMAC1, TEP1, PTEN, Inositol polyphosphate 3-phosphatase, Mutated in multiple advanced cancers 1, Phosphatase and tensin homolog

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PTEN antibody (AB31392)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PTEN antibody (AB31392)

Immunohistochemical analysis of paraffin-embedded breast carcinoma, using anti-PTEN (ab31392, diluted 1 : 100). Left : Untreated; Right : Treated with synthesized peptide.

Western blot - Anti-PTEN antibody (AB31392)
  • WB

Unknown

Western blot - Anti-PTEN antibody (AB31392)

All lanes:

Western blot - Anti-PTEN antibody (ab31392) at 1/100 dilution

Lane 1:

HeLa cells treated with Na<sub>3</sub>VO<sub>4</sub>

Lane 2:

HeLa cells treated with Na<sub>3</sub>VO<sub>4</sub> with Preincubated with synthesized non-phosphopeptide

Predicted band size: 47 kDa

Observed band size: 47 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

Synthetic Peptide within Human PTEN aa 350-400. The exact immunogen used to generate this antibody is proprietary information.

P60484

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The PTEN protein also known as phosphatase and tensin homolog is a phosphatase enzyme with a molecular mass of approximately 47 kDa. It acts mechanically by removing phosphate groups from phosphatidylinositol (345)-trisphosphate (PIP3) converting it to phosphatidylinositol (45)-bisphosphate. PTEN is ubiquitously expressed in various tissues with pronounced presence in the brain lung kidney and testis. This enzyme is an important regulator of cellular functions through its impact on signaling pathways.
Biological function summary

PTEN plays important roles in cellular processes like apoptosis cell proliferation and migration. It negatively regulates the PI3K/AKT signaling pathway critical for cell survival and growth. PTEN is not part of a larger protein complex but interacts with various other proteins modulating its activity. It maintains cellular homeostasis by balancing growth-promoting signals with cell cycle arrest and apoptotic pathways.

Pathways

PTEN is an important component in the PI3K/AKT and mTOR signaling pathways. These pathways regulate cell growth metabolism and survival and are interlinked with insulin signaling and cancer progression. PTEN's function directly interacts with proteins such as AKT and mTOR serving as a checkpoint that ensures controlled cellular proliferation. This positions PTEN as a tumor suppressor inhibiting uncontrolled cell growth via modulation of these pathways.

PTEN mutations or deletions are strongly associated with various types of cancers including breast and prostate cancer. PTEN interaction with the PI3K/AKT pathway influences cancer development often through loss-of-function mutations leading to unrestrained cellular growth. Beyond cancer PTEN mutations also relate to neurological disorders like Autism Spectrum Disorder where it affects signaling pathways involving proteins like mTOR. Understanding PTEN's role aids in unravelling the mechanistic underpinnings of these diseases paving the way for targeted therapeutic interventions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine- and threonine-phosphorylated proteins (PubMed : 9187108, PubMed : 9256433, PubMed : 9616126). Also functions as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring of PtdIns(3,4,5)P3/phosphatidylinositol 3,4,5-trisphosphate, PtdIns(3,4)P2/phosphatidylinositol 3,4-diphosphate and PtdIns3P/phosphatidylinositol 3-phosphate with a preference for PtdIns(3,4,5)P3 (PubMed : 16824732, PubMed : 26504226, PubMed : 9593664, PubMed : 9811831). Furthermore, this enzyme can also act as a cytosolic inositol 3-phosphatase acting on Ins(1,3,4,5,6)P5/inositol 1,3,4,5,6 pentakisphosphate and possibly Ins(1,3,4,5)P4/1D-myo-inositol 1,3,4,5-tetrakisphosphate (PubMed : 11418101, PubMed : 15979280). Antagonizes the PI3K-AKT/PKB signaling pathway by dephosphorylating phosphoinositides and thereby modulating cell cycle progression and cell survival (PubMed : 31492966, PubMed : 37279284). The unphosphorylated form cooperates with MAGI2 to suppress AKT1 activation (PubMed : 11707428). In motile cells, suppresses the formation of lateral pseudopods and thereby promotes cell polarization and directed movement (PubMed : 22279049). Dephosphorylates tyrosine-phosphorylated focal adhesion kinase and inhibits cell migration and integrin-mediated cell spreading and focal adhesion formation (PubMed : 22279049). Required for growth factor-induced epithelial cell migration; growth factor stimulation induces PTEN phosphorylation which changes its binding preference from the p85 regulatory subunit of the PI3K kinase complex to DLC1 and results in translocation of the PTEN-DLC1 complex to the posterior of migrating cells to promote RHOA activation (PubMed : 26166433). Meanwhile, TNS3 switches binding preference from DLC1 to p85 and the TNS3-p85 complex translocates to the leading edge of migrating cells to activate RAC1 activation (PubMed : 26166433). Plays a role as a key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Involved in the regulation of synaptic function in excitatory hippocampal synapses. Recruited to the postsynaptic membrane upon NMDA receptor activation, is required for the modulation of synaptic activity during plasticity. Enhancement of lipid phosphatase activity is able to drive depression of AMPA receptor-mediated synaptic responses, activity required for NMDA receptor-dependent long-term depression (LTD) (By similarity). May be a negative regulator of insulin signaling and glucose metabolism in adipose tissue. The nuclear monoubiquitinated form possesses greater apoptotic potential, whereas the cytoplasmic nonubiquitinated form induces less tumor suppressive ability (PubMed : 10468583, PubMed : 18716620).. Isoform alpha. Functional kinase, like isoform 1 it antagonizes the PI3K-AKT/PKB signaling pathway. Plays a role in mitochondrial energetic metabolism by promoting COX activity and ATP production, via collaboration with isoform 1 in increasing protein levels of PINK1.
See full target information PTEN

Publications (102)

Recent publications for all applications. Explore the full list and refine your search

Discover oncology 15:807 PubMed39692840

2024

Unveiling hsa_circ_0007439: a novel suppressor of nasopharyngeal carcinoma via miR-556-5p/PTEN Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Ming Li,Jing Yang,WanRong Feng,DongXue Fu,Yang Bai

Communications biology 7:747 PubMed38902324

2024

Dorsomorphin inhibits AMPK, upregulates Wnt and Foxo genes and promotes the activation of dormant follicles.

Applications

Unspecified application

Species

Unspecified reactive species

Julie Feld Madsen,Emil Hagen Ernst,Mahboobeh Amoushahi,Margit Dueholm,Erik Ernst,Karin Lykke-Hartmann

International journal of molecular sciences 25: PubMed38339066

2024

Clinical Characteristics and Local Histopathological Modulators of Endometriosis and Its Progression.

Applications

Unspecified application

Species

Unspecified reactive species

Anca-Maria Istrate-Ofiţeru,Carmen Aurelia Mogoantă,George-Lucian Zorilă,Gabriela-Camelia Roşu,Roxana Cristina Drăguşin,Elena-Iuliana-Anamaria Berbecaru,Marian Valentin Zorilă,Cristina Maria Comănescu,Stelian-Ștefăniță Mogoantă,Constantin-Cristian Vaduva,Elvira Brătilă,Dominic Gabriel Iliescu

Molecular therapy. Nucleic acids 35:102120 PubMed38318212

2024

C-Myc/H19/miR-29b axis downregulates nerve/glial (NG)2 expression in glioblastoma multiforme.

Applications

Unspecified application

Species

Unspecified reactive species

Anne S Boewe,Selina Wrublewsky,Jessica Hoppstädter,Claudia Götz,Alexandra K Kiemer,Michael D Menger,Matthias W Laschke,Emmanuel Ampofo

Biomaterials research 27:77 PubMed37563655

2023

Exosomes derived from mir-214-3p overexpressing mesenchymal stem cells promote myocardial repair.

Applications

Unspecified application

Species

Unspecified reactive species

Wenwu Zhu,Qingjie Wang,Jian Zhang,Ling Sun,Xiu Hong,Wei Du,Rui Duan,Jianguang Jiang,Yuan Ji,Haoran Wang,Bing Han

Molecular therapy. Nucleic acids 33:351-366 PubMed37547295

2023

Tumor targeting and therapeutic assessments of RNA nanoparticles carrying α9-nAChR aptamer and anti-miR-21 in triple-negative breast cancers.

Applications

Unspecified application

Species

Unspecified reactive species

You-Cheng Liao,Tzu-Chun Cheng,Shih-Hsin Tu,Jungshan Chang,Peixuan Guo,Li-Ching Chen,Yuan-Soon Ho

Immunity, inflammation and disease 11:e945 PubMed37506155

2023

GAS5 silencing attenuates hypoxia-induced cardiomyocytes injury by targeting miR-21/PTEN.

Applications

Unspecified application

Species

Unspecified reactive species

Qianli Wang,Zan Xie

Journal of biochemical and molecular toxicology 37:e23288 PubMed36756790

2023

LncRNA GABPB1-IT1 inhibits the tumorigenesis of renal cancer via the miR-21/PTEN axis.

Applications

Unspecified application

Species

Unspecified reactive species

Chao Tan,Huasheng Du,Yang Wang,Jianjun Zhao,Xiaolong Cheng,Haihe Lan

Cell proliferation 56:e13350 PubMed36321378

2022

A NR2E1-interacting peptide of LSD1 inhibits the proliferation of brain tumour initiating cells.

Applications

Unspecified application

Species

Unspecified reactive species

Rong Hu,Umar Farook Shahul Hameed,Xiang Sun,Balakrishnan Shenbaga Moorthy,Wen Zhang,Philip D Jeffrey,Li Zhou,Xin Ma,Fangjin Chen,Jianfeng Pei,Pankaj K Giri,Yonggao Mou,Kunchithapadam Swaminathan,Ping Yuan

Journal of biochemical and molecular toxicology 36:e23205 PubMed36224710

2022

Overexpression of miR-383-3p protects cardiomyocytes against hypoxia/reoxygenation injury via regulating PTEN/PI3K/AKT signal pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Huan Zeng,Ying Li,Xinzong Liu,Xinxin Li,Tian Zhou,Shanshan Cao,Mingjuan Wang,Mingfei Ju
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com